- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Musculoskeletal Disorders Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Musculoskeletal Disorders Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Osteoarthritis accounting for % of the Musculoskeletal Disorders Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Musculoskeletal Disorders Therapeutics include AbbVie, Johnson & Johnson, Amgen, Pfizer, and F. Hoffmann-La Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Musculoskeletal Disorders Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biologics
Small Molecules
Market segment by Application, can be divided into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Amgen
Pfizer
F. Hoffmann-La Roche
Eli Lilly
Merck
Novartis
AstraZeneca
Astellas
AB Sciences
3SBio
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Musculoskeletal Disorders Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Musculoskeletal Disorders Therapeutics, with revenue, gross margin and global market share of Musculoskeletal Disorders Therapeutics from 2019 to 2022.
Chapter 3, the Musculoskeletal Disorders Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Musculoskeletal Disorders Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Musculoskeletal Disorders Therapeutics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Musculoskeletal Disorders Therapeutics
1.2 Classification of Musculoskeletal Disorders Therapeutics by Type
1.2.1 Overview: Global Musculoskeletal Disorders Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type in 2021
1.2.3 Biologics
1.2.4 Small Molecules
1.3 Global Musculoskeletal Disorders Therapeutics Market by Application
1.3.1 Overview: Global Musculoskeletal Disorders Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Osteoarthritis
1.3.3 Osteoporosis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.4 Global Musculoskeletal Disorders Therapeutics Market Size & Forecast
1.5 Global Musculoskeletal Disorders Therapeutics Market Size and Forecast by Region
1.5.1 Global Musculoskeletal Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Musculoskeletal Disorders Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Musculoskeletal Disorders Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Musculoskeletal Disorders Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Musculoskeletal Disorders Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Musculoskeletal Disorders Therapeutics Market Drivers
1.6.2 Musculoskeletal Disorders Therapeutics Market Restraints
1.6.3 Musculoskeletal Disorders Therapeutics Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Musculoskeletal Disorders Therapeutics Product and Solutions
2.1.4 AbbVie Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Product and Solutions
2.2.4 Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Musculoskeletal Disorders Therapeutics Product and Solutions
2.3.4 Amgen Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Amgen Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Musculoskeletal Disorders Therapeutics Product and Solutions
2.4.4 Pfizer Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business
2.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product and Solutions
2.5.4 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Product and Solutions
2.6.4 Eli Lilly Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Musculoskeletal Disorders Therapeutics Product and Solutions
2.7.4 Merck Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merck Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Musculoskeletal Disorders Therapeutics Product and Solutions
2.8.4 Novartis Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Novartis Recent Developments and Future Plans
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Product and Solutions
2.9.4 AstraZeneca Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 AstraZeneca Recent Developments and Future Plans
2.10 Astellas
2.10.1 Astellas Details
2.10.2 Astellas Major Business
2.10.3 Astellas Musculoskeletal Disorders Therapeutics Product and Solutions
2.10.4 Astellas Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Astellas Recent Developments and Future Plans
2.11 AB Sciences
2.11.1 AB Sciences Details
2.11.2 AB Sciences Major Business
2.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Product and Solutions
2.11.4 AB Sciences Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 AB Sciences Recent Developments and Future Plans
2.12 3SBio
2.12.1 3SBio Details
2.12.2 3SBio Major Business
2.12.3 3SBio Musculoskeletal Disorders Therapeutics Product and Solutions
2.12.4 3SBio Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 3SBio Recent Developments and Future Plans
2.13 Samsung Bioepis
2.13.1 Samsung Bioepis Details
2.13.2 Samsung Bioepis Major Business
2.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Product and Solutions
2.13.4 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Samsung Bioepis Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Musculoskeletal Disorders Therapeutics Product and Solutions
2.14.4 Sanofi Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sanofi Recent Developments and Future Plans
2.15 Taisho Pharmaceutical
2.15.1 Taisho Pharmaceutical Details
2.15.2 Taisho Pharmaceutical Major Business
2.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product and Solutions
2.15.4 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Taisho Pharmaceutical Recent Developments and Future Plans
2.16 Takeda
2.16.1 Takeda Details
2.16.2 Takeda Major Business
2.16.3 Takeda Musculoskeletal Disorders Therapeutics Product and Solutions
2.16.4 Takeda Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Takeda Recent Developments and Future Plans
2.17 Zosano Pharma
2.17.1 Zosano Pharma Details
2.17.2 Zosano Pharma Major Business
2.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Product and Solutions
2.17.4 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Zosano Pharma Recent Developments and Future Plans
2.18 LG Life Sciences
2.18.1 LG Life Sciences Details
2.18.2 LG Life Sciences Major Business
2.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Product and Solutions
2.18.4 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 LG Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Musculoskeletal Disorders Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Musculoskeletal Disorders Therapeutics Players Market Share in 2021
3.2.2 Top 10 Musculoskeletal Disorders Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Musculoskeletal Disorders Therapeutics Players Head Office, Products and Services Provided
3.4 Musculoskeletal Disorders Therapeutics Mergers & Acquisitions
3.5 Musculoskeletal Disorders Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Musculoskeletal Disorders Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Musculoskeletal Disorders Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Musculoskeletal Disorders Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2028)
6.2 North America Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2028)
6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Country
6.3.1 North America Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2028)
7.2 Europe Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2028)
7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Country
7.3.1 Europe Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region
8.3.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Region (2017-2028)
8.3.2 China Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2028)
9.2 South America Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2028)
9.3 South America Musculoskeletal Disorders Therapeutics Market Size by Country
9.3.1 South America Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country
10.3.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Musculoskeletal Disorders Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Musculoskeletal Disorders Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Musculoskeletal Disorders Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Musculoskeletal Disorders Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Musculoskeletal Disorders Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Musculoskeletal Disorders Therapeutics Product and Solutions
Table 9. AbbVie Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product and Solutions
Table 13. Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Amgen Corporate Information, Head Office, and Major Competitors
Table 15. Amgen Major Business
Table 16. Amgen Musculoskeletal Disorders Therapeutics Product and Solutions
Table 17. Amgen Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Musculoskeletal Disorders Therapeutics Product and Solutions
Table 21. Pfizer Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Major Business
Table 24. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product and Solutions
Table 25. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Musculoskeletal Disorders Therapeutics Product and Solutions
Table 29. Eli Lilly Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Musculoskeletal Disorders Therapeutics Product and Solutions
Table 33. Merck Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Novartis Corporate Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Musculoskeletal Disorders Therapeutics Product and Solutions
Table 37. Novartis Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Musculoskeletal Disorders Therapeutics Product and Solutions
Table 41. AstraZeneca Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Astellas Corporate Information, Head Office, and Major Competitors
Table 43. Astellas Major Business
Table 44. Astellas Musculoskeletal Disorders Therapeutics Product and Solutions
Table 45. Astellas Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. AB Sciences Corporate Information, Head Office, and Major Competitors
Table 47. AB Sciences Major Business
Table 48. AB Sciences Musculoskeletal Disorders Therapeutics Product and Solutions
Table 49. AB Sciences Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. 3SBio Corporate Information, Head Office, and Major Competitors
Table 51. 3SBio Major Business
Table 52. 3SBio Musculoskeletal Disorders Therapeutics Product and Solutions
Table 53. 3SBio Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Samsung Bioepis Corporate Information, Head Office, and Major Competitors
Table 55. Samsung Bioepis Major Business
Table 56. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product and Solutions
Table 57. Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sanofi Corporate Information, Head Office, and Major Competitors
Table 59. Sanofi Major Business
Table 60. Sanofi Musculoskeletal Disorders Therapeutics Product and Solutions
Table 61. Sanofi Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Taisho Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 63. Taisho Pharmaceutical Major Business
Table 64. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product and Solutions
Table 65. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Takeda Corporate Information, Head Office, and Major Competitors
Table 67. Takeda Major Business
Table 68. Takeda Musculoskeletal Disorders Therapeutics Product and Solutions
Table 69. Takeda Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Zosano Pharma Corporate Information, Head Office, and Major Competitors
Table 71. Zosano Pharma Major Business
Table 72. Zosano Pharma Musculoskeletal Disorders Therapeutics Product and Solutions
Table 73. Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. LG Life Sciences Corporate Information, Head Office, and Major Competitors
Table 75. LG Life Sciences Major Business
Table 76. LG Life Sciences Musculoskeletal Disorders Therapeutics Product and Solutions
Table 77. LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Musculoskeletal Disorders Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Musculoskeletal Disorders Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Musculoskeletal Disorders Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Musculoskeletal Disorders Therapeutics Players Head Office, Products and Services Provided
Table 82. Musculoskeletal Disorders Therapeutics Mergers & Acquisitions in the Past Five Years
Table 83. Musculoskeletal Disorders Therapeutics New Entrants and Expansion Plans
Table 84. Global Musculoskeletal Disorders Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 85. Global Musculoskeletal Disorders Therapeutics Revenue Share by Type (2017-2022)
Table 86. Global Musculoskeletal Disorders Therapeutics Revenue Forecast by Type (2023-2028)
Table 87. Global Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022)
Table 88. Global Musculoskeletal Disorders Therapeutics Revenue Forecast by Application (2023-2028)
Table 89. North America Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Musculoskeletal Disorders Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Musculoskeletal Disorders Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Musculoskeletal Disorders Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Musculoskeletal Disorders Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Musculoskeletal Disorders Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Musculoskeletal Disorders Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Musculoskeletal Disorders Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Musculoskeletal Disorders Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Musculoskeletal Disorders Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Musculoskeletal Disorders Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Musculoskeletal Disorders Therapeutics Picture
Figure 2. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type in 2021
Figure 3. Biologics
Figure 4. Small Molecules
Figure 5. Musculoskeletal Disorders Therapeutics Revenue Market Share by Application in 2021
Figure 6. Osteoarthritis Picture
Figure 7. Osteoporosis Picture
Figure 8. Psoriatic Arthritis Picture
Figure 9. Ankylosing Spondylitis Picture
Figure 10. Fibromyalgia Picture
Figure 11. Global Musculoskeletal Disorders Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Musculoskeletal Disorders Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Region (2017-2028)
Figure 14. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Region in 2021
Figure 15. North America Musculoskeletal Disorders Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Musculoskeletal Disorders Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Musculoskeletal Disorders Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Musculoskeletal Disorders Therapeutics Market Drivers
Figure 21. Musculoskeletal Disorders Therapeutics Market Restraints
Figure 22. Musculoskeletal Disorders Therapeutics Market Trends
Figure 23. AbbVie Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Novartis Recent Developments and Future Plans
Figure 31. AstraZeneca Recent Developments and Future Plans
Figure 32. Astellas Recent Developments and Future Plans
Figure 33. AB Sciences Recent Developments and Future Plans
Figure 34. 3SBio Recent Developments and Future Plans
Figure 35. Samsung Bioepis Recent Developments and Future Plans
Figure 36. Sanofi Recent Developments and Future Plans
Figure 37. Taisho Pharmaceutical Recent Developments and Future Plans
Figure 38. Takeda Recent Developments and Future Plans
Figure 39. Zosano Pharma Recent Developments and Future Plans
Figure 40. LG Life Sciences Recent Developments and Future Plans
Figure 41. Global Musculoskeletal Disorders Therapeutics Revenue Share by Players in 2021
Figure 42. Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Musculoskeletal Disorders Therapeutics Revenue Market Share in 2021
Figure 44. Global Top 10 Players Musculoskeletal Disorders Therapeutics Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Musculoskeletal Disorders Therapeutics Revenue Share by Type in 2021
Figure 47. Global Musculoskeletal Disorders Therapeutics Market Share Forecast by Type (2023-2028)
Figure 48. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application in 2021
Figure 49. Global Musculoskeletal Disorders Therapeutics Market Share Forecast by Application (2023-2028)
Figure 50. North America Musculoskeletal Disorders Therapeutics Sales Market Share by Type (2017-2028)
Figure 51. North America Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2017-2028)
Figure 52. North America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country (2017-2028)
Figure 53. United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Musculoskeletal Disorders Therapeutics Sales Market Share by Type (2017-2028)
Figure 57. Europe Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2017-2028)
Figure 58. Europe Musculoskeletal Disorders Therapeutics Revenue Market Share by Country (2017-2028)
Figure 59. Germany Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Musculoskeletal Disorders Therapeutics Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue Market Share by Region (2017-2028)
Figure 67. China Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Musculoskeletal Disorders Therapeutics Sales Market Share by Type (2017-2028)
Figure 74. South America Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2017-2028)
Figure 75. South America Musculoskeletal Disorders Therapeutics Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Musculoskeletal Disorders Therapeutics Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
